Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. We currently market two autologous cell therapy products and one specialty biologic product in the United States. Personal integrity, teamwork, collaboration, and innovative technology are the foundations of our work. We seek to practice transparency in our clinical trials and research, and in our relationships with each other, our patients, and the investors who support us. PRIVACY AND COMMUNITY GUIDELINES When you engage with Vericel social media channels and our content providers on social media, you also agree to abide by the following Community Guidelines (found here: https://bit.ly/3pg3UKQ), which apply in addition to the Terms and Conditions or other legal notices specific to each social media channel. Please note that third-party social media channels also have access to information you share via social media. For more details, read LinkedIn's Privacy Policy here: https://bit.ly/3GF2r5Y. For additional information about privacy at Vericel, please see our Privacy Policy (bit.ly/43ErZcx) and Terms and Conditions of Use (bit.ly/4568Cdx). If you engage with us, you consent and give Vericel permission to communicate with you and to use any information, text and media associated with the interaction or post.
View Top Employees from Vericel® CorporationWebsite | http://www.vcel.com |
Ticker | VCEL |
Revenue | $157.7 million |
Funding | $313.8 million |
Employees | 351 (314 on RocketReach) |
Founded | 1989 |
Address | 64 Sidney Sreet, Cambridge, Massachusetts 02139, US |
Phone | (617) 588-5555 |
Fax | (617) 588-5554 |
Technologies |
JavaScript,
HTML,
Google Analytics
+53 more
(view full list)
|
Industry | Biotechnology, Pharmaceuticals, Biotechnology Research, Drug Manufacturing & Research, Biologics, Science and Engineering, Cell Therapy, Healthcare, Life Science, Clinical Research, Therapeutics, Multicellular Therapy Development, Health Care, Clinical Trials, Automated cell-processing system |
Web Rank | 2 Million |
Keywords | Vericel, Vericel Corporation, Vericel Essentials Kit, Public Company Based In Boston In Biotech That Is Working On Knee Cartlidge, Vcel Corportation |
Competitors | CBMG Holdings, Celularity Inc., Gamida Cell Ltd., Orgenesis Belgium, SQZ Biotechnologies |
SIC | SIC Code 873 Companies, SIC Code 28 Companies, SIC Code 87 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 6215 Companies, NAICS Code 62151 Companies, NAICS Code 3254 Companies, NAICS Code 621 Companies, NAICS Code 62 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Vericel® Corporation employee's phone or email?
The Vericel® Corporation annual revenue was $157.7 million in 2024.
Michael Halpin is the COO of Vericel® Corporation.
314 people are employed at Vericel® Corporation.
Vericel® Corporation is based in Cambridge, Massachusetts.
The NAICS codes for Vericel® Corporation are [6215, 62151, 3254, 621, 62, 32, 325].
The SIC codes for Vericel® Corporation are [873, 28, 87, 283].